
    
      The primary endpoint is the 'qualified success' rate at 6 months after surgery greater than
      60%. 'Qualified success' is defined as a diurnal IOP â‰¤ 21mmHg (millimeter mercury) and >
      5mmHg with a minimum 20% diurnal IOP reduction from baseline with or without the concomitant
      use of allowed glaucoma hypotensive medication at 6 months after surgery
    
  